• Subscribe
  • Magazines
  • About
  • Contact
  • Advertise
Friday 9 May 2025
  • zh-hant 中文
  • ja 日本語
  • en English
IAG
Advertisement
  • Newsfeed
  • Mag Articles
  • Video
  • Opinion
  • Tags
  • Regional
    • Africa
    • Australia
    • Cambodia
    • China
    • CNMI
    • Europe
    • Hong Kong
    • India
    • Japan
    • Laos
    • Latin America
    • Malaysia
    • Macau
    • Nepal
    • New Zealand
    • North America
    • North Korea
    • Philippines
    • Russia
    • Singapore
    • South Korea
    • Sri Lanka
    • Thailand
    • UAE
    • Vietnam
  • Events
  • Contributors
  • SUBSCRIBE FREE
  • 中文
  • 日本語
No Result
View All Result
IAG
  • Newsfeed
  • Mag Articles
  • Video
  • Opinion
  • Tags
  • Regional
    • Africa
    • Australia
    • Cambodia
    • China
    • CNMI
    • Europe
    • Hong Kong
    • India
    • Japan
    • Laos
    • Latin America
    • Malaysia
    • Macau
    • Nepal
    • New Zealand
    • North America
    • North Korea
    • Philippines
    • Russia
    • Singapore
    • South Korea
    • Sri Lanka
    • Thailand
    • UAE
    • Vietnam
  • Events
  • Contributors
  • SUBSCRIBE FREE
  • 中文
  • 日本語
No Result
View All Result
IAG
No Result
View All Result

Macau scientists outline importance of new COVID-19 vaccine breakthrough

Ben Blaschke by Ben Blaschke
Mon 3 Aug 2020 at 06:15
Macau scientists outline importance of new COVID-19 vaccine breakthrough
158
SHARES
3.9k
VIEWS
Print Friendly, PDF & Email

Scientists involved in potentially game changing research into a COVID-19 vaccine out of the Faculty of Medicine at Macau University of Science and Technology (MUST) have outlined the key findings of their work, suggesting mass production of the vaccine could be feasible in the near future.

As previously reported by Inside Asian Gaming, the team from MUST, working in collaboration with scientists from mainland China and Hong Kong, found that a vaccine developed using certain residues found in the Spike protein receptor-binding domain (S-RBD) – which is what the virus uses to engage with the cells of the host and cause infection – induced a “potent functional antibody response” in immunized mice, rabbits and monkeys.

These antibodies effectively blocked S-RBD from binding with the host cell receptor as it does in cases of infection, therefore neutralizing the virus during laboratory studies.

The peer-reviewed results from the team’s research were published in the leading British science journal Nature last Wednesday 29 July.

Via a press release shedding further light on their work, Professor Kang Zhang from MUST, who led the collaborative research team, stated, “Our finding highlights the importance of the RBD domain in the SARS-CoV-2 (COVID-19) vaccine design and provides the rationale for the development of a protective vaccine through the induction of antibody against the RBD domain.

“The objective of this study was to evaluate the potential of a candidate vaccine based on the RBD domain of SARS-CoV-2, to evaluate the appropriate dosing regime and to test its effect in generating neutralizing activity against SARS-CoV-2 in the recipient animals, and determine the immune pathways involved in the generation of the immune response, so as to provide the groundwork for the design of an effective SARS-CoV-2 preventive vaccine.

“The vaccine had given a potent and complete protection of vaccinated animals including monkeys.”

Dr Johnson Lau, Adjunct Professor of the Department of Applied Biology and Chemical Technology of PolyU, explained that the biotechnology method used in creating the recombinant RBD vaccine is mature and feasible in aiding a mass vaccine production and is expected to provide a practical solution to fight against COVID-19.

Professor Alexander Wai, Deputy President and Provost of PolyU said the vaccine shapes as “the best vaccine choice to combat this pandemic.”

The next step, according to Dean of the Faculty of Medicine of MUST, Professor Manson Fok, will be to initiate human trials with the clear goal of mass production.

“To move forward, the efficacy of the vaccine needs to be evaluated and validated in human clinical trials which will be initiated shortly,” he said.

“With our concerted efforts this breakthrough in COVID-19 vaccine is achieved and we wish mass vaccinations can be conducted in the nearest future.”

RelatedPosts

Winds of change

Melco says working with potential buyers on bidding process for City of Dreams Manila

Fri 9 May 2025 at 06:16
Melco prices US$750 million Senior Notes offering

Melco smashes revenue and profit estimates in 1Q25, gains market share on powerful performance of Macau resorts

Fri 9 May 2025 at 05:36
Galaxy Macau to host 2025 Annual Conference of the FIA – world motorsport’s governing body

Favorable VIP hold pushes Galaxy Entertainment Group’s 1Q25 profit to US$412 million

Thu 8 May 2025 at 14:03
Solutions Showcase: Angel – Tech Minded

Side bets now contribute close to 50% of Macau baccarat revenues

Thu 8 May 2025 at 13:32
Load More
Tags: Chinacovid-19Hong KongMacauMacau University of Science and TechnologyMUSTProfessor Zhang KangSARS-CoV-2Vaccination
Share63Share11
Ben Blaschke

Ben Blaschke

A former sports journalist in Sydney, Australia, Ben has been Managing Editor of Inside Asian Gaming since early 2016. He played a leading role in developing and launching IAG Breakfast Briefing in April 2017 and oversees as well as being a key contributor to all of IAG’s editorial pursuits.

Current Issue

Editorial – Knife’s edge

Editorial – Knife’s edge

by Andrew W Scott and Ben Blaschke
Tue 29 Apr 2025 at 15:14

Thailand’s Entertainment Complex journey is at a critical point, with the success or failure of the initiative to be determined...

The changing face of Macau

The changing face of Macau

by Ben Blaschke
Tue 29 Apr 2025 at 15:09

Inside Asian Gaming takes a deep dive into the new, post-COVID Macau where a revenue environment that seems to be...

Born again

Born again

by Pierce Chan
Tue 29 Apr 2025 at 14:47

Premiering in September 2010 at City of Dreams, The House of Dancing Water was a visionary creation by artistic maestro...

Richard Howarth – Testing the limits

Richard Howarth – Testing the limits

by Ben Blaschke
Tue 29 Apr 2025 at 13:17

Richard Howarth, Chief Business Officer APAC for global testing laboratory GLI, discusses his career journey and his passion for fast-paced...

Evolution Asia
Aristocrat
GLI
Mindslot
Solaire
Hann
Tecnet
Nustar
Jumbo

Related Posts

Japan Credit Rating Agency affirms Konami’s A+ rating due to “high earning capacity”

Stability in Australia, North America drives 7.4% revenue growth for Konami’s gaming segment in FY25

by Newsdesk
Fri 9 May 2025 at 06:48

Global gaming supplier Konami reported a 7.4% increase in revenue in its Gaming & Systems segment to JPY42.7 billion in the year ended 31 March 2025, with operating profit up by 16.3% to JPY7.3 billion, according to financial statements published...

MGM’s Hornbuckle bullish on “unique” Macau as China stimulus uncertainty sees gaming stocks dive

MGM’s Bill Hornbuckle extends employment contract through end-2028

by Ben Blaschke
Fri 9 May 2025 at 06:34

MGM Resorts CEO and President Bill Hornbuckle has renewed his employment contract with the company through to the end of 2028, after which time he will assume an advisory role to assist with the pre-opening phase of its US$9 billion...

Winds of change

Melco says working with potential buyers on bidding process for City of Dreams Manila

by Ben Blaschke
Fri 9 May 2025 at 06:16

Melco Resorts & Entertainment said Thursday that it is currently in discussions with potential buyers of its stake in Philippines integrated resort City of Dreams Manila and will soon have a shortlist of interested parties that will partake in a...

Melco prices US$750 million Senior Notes offering

Melco smashes revenue and profit estimates in 1Q25, gains market share on powerful performance of Macau resorts

by Ben Blaschke
Fri 9 May 2025 at 05:36

An impressively strong performance in Macau was enough to see Melco Resorts & Entertainment comfortably beat consensus in 1Q25, with the company reporting a 10.8% year-on-year increase in total operating revenues to US$1.23 billion including a 12.2% rise in gaming...



IAG

© 2005-2024
Inside Asian Gaming.
All rights reserved.

  • SUBSCRIBE FREE
  • NEWSFEED
  • MAG ARTICLES
  • VIDEO
  • OPINION
  • TAGS
  • REGIONAL
  • EVENTS
  • CONSULTING
  • CONTRIBUTORS
  • MAGAZINES
  • ABOUT
  • CONTACT
  • ADVERTISE
  • 中文
  • 日本語

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • 中文
  • 日本語
  • Subscribe
  • Newsfeed
  • Mag Articles
  • Video
  • Opinion
  • Tags
  • Regional
  • Events
  • Contributors
  • Magazines
  • Advertise
  • Contact
  • About
  • Home for G2E Asia

© 2005-2024
Inside Asian Gaming.
All rights reserved.

  • 中文
  • English
  • 日本語